Use of transgenic animals to investigate drug hypersensitivity

Toxicology

Volumn 158, Issue 1-2, 2001, Pages 75-83

  Moser, Rene ^a   Quesniaux, Valerie ^a   Ryffel, Bernhard ^b,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c CNRS   (France)

Author keywords

Allergy; Asthma; Cytokine transgenic mice; Eczema

Indexed keywords

CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; VASOPRESSIN;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; DRUG HYPERSENSITIVITY; GENE EXPRESSION REGULATION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; DRUG HYPERSENSITIVITY; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; PHARMACEUTICAL PREPARATIONS; TH2 CELLS; XENOBIOTICS;

ANIMALIA; MUS MUSCULUS;

EID: 0035793420     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00411-X     Document Type: Article

References (67)

1. Functional diversity of helper T lymphocytes
2. Decline in total serum IgE after treatment for tuberculosis
3. Human chemokines: An update
4. The genetic and complexity of allergy and asthma
5. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses
6. Clinical aspects of respiratory hypersensitivity to chemicals
7. Transgenic animals as pharmacological tools
8. The use of transgenic mouse models to investigate the immune mechanisms of allergic contact dermatitis: An area of emerging opportunities
9. Value of animals models for predicting hypersensitivity reactions to medicinal products
10. 2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils
11. Mechanisms of drug allergy
12. Asthma: An epidemic in the absence of infection?
13. Disseminated tuberculosis in interferon gamma gene-disrupted mice
14. Interleukin 12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
15. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
16. Eosinophilia in transgenic mice expressing interleukin 5
17. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
18. Impaired contact hypersensitivity to trinitrochlorbenzene in interleukin-4-deficient mice
19. IL-9 induces chemokine expression in lung epithelial cells and baseline airways eosinphilia in transgenic mice
20. Atopic disorders: A default pathway in the absence of infection?
21. Infection of mice with mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen induced airway eosinophilia
22. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin double deficient mice
23. Walking through the forest of transgenic models c human disease
24. T cell-dependent immune reactions to reactive benzene metabolites in mice
25. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity
26. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
27. Allergic and autoimmune reactions to xenobiotics: How do they arise?
28. The genetic basis of atopic asthma
29. Is allergy increasing? - Early life influences
30. Immune response in mice that lack the interferon-gamma receptor
31. Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: Importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase
32. Langerhans cells and chemical allergy
33. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: An interlaboratory evaluation
34. IL-5-deficient mice have a development defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
35. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen is sensitized mice
36. Interleukin-5 expression in the lung epithelium of transgenic mice leadsto pulmonary changes pathognomonic of asthma
37. Mutant and transgenic mice in immunotoxicology: An introduction
38. Involvement of interleukin-3 in delayed-type hypersensitivity
39. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses
40. Characterization of tumor necrosis factor-deficient mice
41. Impaired development of Th2 cells in IL-13-deficient mice
42. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in I helper cell type 2-mediated responses
43. Asthma: Recent advances
44. Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allegic cutaneous response in mice
45. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the information of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
46. Conditional gene targeting
47. Editorial overview: Interactions between genetic susceptibility innocous and/or microbial antignes and the immune system
48. Impact of knockout mice in toxicology
49. Role of interferon-γ in contact hypersensitivity assessed in interferon-γ receptor-deficient mice
50. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction
51. The inverse association between tuberculin responses and atopic disorders
52. Gamma delta T cells, allergen recognition and airway inflammation
53. Genetic susceptibility to experimental uveitis involves more than a predisposition to genet a T helper-1-like or a helper-2-like response
54. Defective NK cell activity and Th1 response in IL-18-deficient mice
55. HLA transgenic mice as humanized mouse of disease and immunity
56. IL-4 induces allergic allergic-like inflammatory disease and alters T cell development transgenic mice
57. What can we learn from murine models of asthma?
58. Enhanced epidermal cell migration in IL-10 knockout mice
59. Trangenic animals as new approaches in pharmacological studies
60. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-I 8-deficient mice
61. Interleukin-13: Central mediator of allergic asthma
62. Immunological basis of antigen induced airway hyperresponsiveness
63. Evidence gor the increase in asthma worldwide
64. Characterization of lidocaine-specific T cells
65. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production